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The  cellular  immune  reactions  to  hapten-protein  conjugates  (in  the  generation  of 
hapten-specific primary and secondary humoral responses) display a significant depend- 
ence upon carrier recognition (reviewed in reference 1).  Experimental models, particu- 
larly the adoptive transfer of immunocompetent cells into irradiated hosts (2-5), have 
established  that  the  cooperative  interactions  involved  require  a  thymus-derived  (T) 
lymphocyte (6) with specificity for the carrier protein (7-9) to induce an optimal response 
by hapten-primed, antibody-forming precursors (B cells). In vivo methods for generating 
carrier-reactive T-helper cells include preimmunization with free carrier before immuni- 
zation with hapten-carrier conjugate (10, 11), adoptive transfer of carrier primed cells 
(6-9),  and the use of thymus-derived cells obtained from spleens of irradiated mice in- 
jected with thymocytes and carrier (12-14).  These cells, or products derived from them, 
have been analyzed in vlvo (12-15)  and in vitro (16-18) 
The critical role of the macrophage in a variety of T-cell responses (19-25) suggests that 
an in vitro system in which macrophage-thymocyte synergy is used might be devised for 
generating carrier-reactive T cells. Cultured, adherent cells have been shown to substan- 
tially preserve thymocyte viability and function  in vitro  (26), and have been used to 
selectively enrich antigen-reactive T cells from mice primed in vivo (27). Until recently it 
has not been possible to generate carrmr-reactive T-helper cells in vitro. In 1973, Konti- 
anen and Feldmann (28) reported the induction of carrier-specific helper T cells in vitro 
by using spleen and lymph node cells as a source of unprimed T cells. Subsequently, Erb 
and Feldmann (29-31) have obtained evidence that interaction between macrophages and 
T cells is essential to the generation of carrier-specific T-helper cells. A detailed examina- 
tion of the cellular requirements, antigen specificity, or mode of action of T-helper cells 
generated in wtro has not been reported. 
The following experiments were initiated to determine whether helper T cells 
could be generated  in vitro from purified  cell populations.  The  expectation is 
that such a  system would be a valuable model for examining the mechanism by 
which T-helper cells or their products enhance B-cell anti-hapten responses. We 
report  the  culture  conditions  and  the  cellular  and  antigen  requirements  for 
generating  cells  active  in  enhancing  a  hapten-specific  response in  vitro.  The 
results provide evidence that:  (a) the active cell is thymus derived, but requires 
macrophages  for  generation  of helper  cell  function;  (b)  the  culture  system 
* The research described in this report involved ammals maintained m animal care facihtles 
fully accredited by the American Association for Accreditation of Laboratory Animal Care. Use of 
trade names is for identification  only and does not constitute endorsement by the Public Health 
Service or by the U  S  Department of Health, Education,  and Welfare 
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represents a true induction rather than enrichment of helper cells; (c) enhance- 
ment of a  carrier-specific  as well as nonspecific response is generated;  and (d) 
the enhancement of a carrier-specific  response requires an additional influence 
of macrophages to demonstrate enhanced anti-hapten B-cell responses, whereas 
the enhancement of the nonspecific response is not macrophage dependent. 
Materials and Methods 
Ammals.  (B10D2  ×  BALB/C) FI  hybrid and CBA/J mice were used.  The F~  hybrids were 
raised m  our animal facilities.  The parental strains and CBA/J mine were obtained from The 
Jackson  Laboratory,  Bar  Harbor,  Maine.  Both  sexes  were  used,  however,  within  any  given 
experiment, mice of the same sex were used. 
Antigens.  2,4-dmitrophenyl  (DNP) ~ groups  were  coupled  to  keyhole  hmpet  hemocyanin 
(KLH) and fowl gamma globulin (FTG) by the method of Little and Eisen (32).  Conjugation ratios 
were 123 mol DNP per 800,000 g KLH and 33 mol DNP per 160,000  g FyG. DNP-N-2-aminoethyl 
carbamylmethylated Flcoll (DNP-Ficoll) containing 39 mol DNP per 400,000 g Ficoll was prepared 
by the method of Inman (33) 
Medm and Culture Conditions.  Eagle's minimal essential media  (MEM) made with Earle's 
salt base  was  prepared  from concentrated  stock  soluhons  (Center for  Disease  Control  Tissue 
Culture  Unit)  diluted  to  300-308  mosmol/liter  at  pH  7.2-7 4.  Supplemented  MEM  contamed 
nonessential amino acids,  1 mM Na pyruvate, 2 mM L-glutamine, 100 U/ml penicilhn, 50/~g/ml 
streptomycin, and 5  x  10  -5 M 2-mercaptoethanol (2-ME)  MEM containing 10 mM N-2-hydroxy- 
ethyl  piperazme-N~-2-ethane  sulfonic  acid  (Calbiochem,  San  Diego,  Calif.),  pH  7.2  (HEPES 
MEM), and 10% fetal calf serum (FCS) (Grand Island Biological Co.,  Grand Island, N  Y.) was 
used for cell  preparations  and culture.  Cells  were  cultured  in  1.0-ml vol  in  Marbrook-Diener 
chambers (34) within a  1.5 cm inner chamber. The reservoir, 30-35 ml, contained supplemented 
MEM and 5% FCS.  Cells were cultured at 37°C in 10% CO2 in humidified air 
Cortisone-Resistant Thymocytes.  Thymuses from 4- to 6-wk-old mice, rejected lntraperitone- 
ally (i.p.) 2 days previously with 2.5 mg cortisone acetate, were aseptically removed taking care to 
avoxd parathymic lymph nodes  Thymocytes were teased from the capsules through a no. 60-mesh 
stainless steel screen and washed twice at 300g with HEPES MEM. Thymocytes were then passed 
through a  nylon wool column (35). 
Macrophages  Peritoneal  exudate  cells  (PEC)  from  mice  injected  i.p.  with  1  cmz  of  10% 
proteose peptone broth (Difco Laboratories,  Detroit,  Mich.) 4 days previously were obtained by 
peritoneal lavage with cold HEPES MEM containing 10 U/ml heparin. PEC were washed, plated 
on 15- by 100-mm plastic Petri dishes (Falcon Plastics, Oxnard, Calif ) at 2-3 x  107 cells per dish in 
20 ml HEPES MEM 10% FCS. Plates were incubated 90 mm at 37°C on a rocker platform (Bellco 
Glass, Vineland, N. J.). Nonadherent cells were vigorously washed off, and m  some experiments, 
the remaining cells treated with anh-Thy-l.2 sera and complement (see below)  Adherent cells 
were harvested with a  rubber policeman, and dead cells were removed by rapid filtration over 
cotton wool m  a  low ionic strength buffer at 4°C  (36). 
Alternatively, 8-15  x  10  e PEC in 1 5 ml were drawn into a  3.0-ml plastic syringe fitted with a 
no.  20-gauge  needle.  The syringe contained 1.5  ml glass beads  (CPG-10,  20/80 mesh,  Electro- 
Nucleonics Inc., Fairfield, N. J.) which had been previously eqmlibrated with HEPES MEM 10% 
FCS.  The  syringe  was  incubated for  1  h  at  37°C  on a  rocker platform  with frequent  manual 
rotation. Nonadherent cells were removed by dropwise elutlon with 15-20 ml ofprewarmed medm 
by using gentle pressure on the plunger.  Cells adhering to the glass beads were calculated by 
subtracting the number eluted from the syringe from the number introduced.  Glass beads were 
removed by cutting the end of the syringe with a hot scalpel and introducing measured amounts of 
glass beads directly into culture vessels by advancing the plunger. 
1 Abbreviations used in this paper: ATC, in vitro activated thymus-derived cell; CRL, lympho- 
cyte with receptor for complement; DNP, dinitrophenyl; FCS, fetal calf serum, FTG, fowl gamma 
globulin; SIg, cell surface immunoglobulin; KLH,  keyhole hmpet hemocyanin; MEM, minimum 
essenhal media; NMS, normal mouse serum; PEC, peritoneal exudate cells; PFC, plaque-forming 
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Hapten-Pnmed  Spleen  Cells  Spleens from mine injected l.p  with 25  ~g DNP-Ficoll 3-4 mo 
previously were removed aseptically. Cells were gently teased from the cut capsule, expressed 
through a  no.  60-mesh stainless steel screen, and washed twice in HEPES MEM; clumps and 
debris were allowed to settle at unit grawty, and the supernate containing a single cell suspension 
was adjusted to the desired concentration for culture. 
Sequentml  Culture  Technique.  Unless stated otherwise, the standard procedure used is as 
follows. 1 5 ×  107 nylon wool-purified, cortisone-resistant thymocytes and 5 ×  105 glass-adherent 
PEC were cultured with carrmr antigen (0.1  ~g KLH or 0 5 ~g F~/G) in 1.0 ml HEPES MEM 10% 
FCS m  Marbrook-Diener culture chambers. After 4 days, the cells were harvested, and the debms 
and glass beads were allowed to settle through a layer of FCS at unit grav:ty. The supernate was 
pelleted at 300 g  for 7 mm and resuspended in fresh media.  A  quantity of the cell suspensmn 
contaimng 5-10  ×  l0  s viable cells was then transferred to cultures containing spleen cells from 
hapten-pmmed mice together with hapten-protem conjugates (1 ~g DNP-KLH or 5 ~g DNP-FTG). 
The recipient cultures contained 15 × l0  s cells  After 4 days, triplicate cultures were harvested and 
assayed for DNP-specific plaque-forming cells (DNP-PFC)  All experiments reported here were 
done at least three times. 
PFC Assay  D:rect PFC were assayed by the Cunnmgham Szenberg mod:ficatlon of the Jerne 
hemolytic-plaque  techmque  (37) with  2,4,6,-trm:trophenyl-conjugated sheep  red  blood  cells 
(SRBC) (38) Specific DNP-PFC were calculated by subtracting the number of PFC formed in the 
presence of 5 x  10 -4 M e-DNP-L-lysine (Sigma Chemical Co., St. Louis, Mo.) from the number of 
PFC formed m the absence of free hapten  Indirect (IgG) PFC were enumerated inhibiting direct 
PFC with a  goat ant:-mouse ~-chain serum (>90% inhibition) and developing IgG PFC with a 
rabbit anti-mouse T-chain serum (39) 
Depletmn of T Lymphocytes  w~th Antz-Thy-1 2  Serum  Antl-Thy-l.2 serum  (anti-O) with a 
plateau mlcrocytotomcity titer of 1:128 (1  ~1 serum/3  ×  l0  s cells) was prepared according to the 
method of Reif and Allen (40)  A  1:3 final dilution of anti-Thy-l.2 serum in HEPES MEM was 
reacted with cell suspensmns of no more than 2 ×  107 cells per ml for 30 min at room temperature. 
The cells were pelleted and resuspended m a 1:10 dilution of guinea pig complement containing 10 
~g/ml deoxyribonuclease (DNAse) (Worthington Biochemical Company, Freehold, N. J  ) for 1 h at 
37°C  The complement had prewously been absorbed at 4°C with CBA or (B10D2  ×  BALB/c) F~ 
spleen cells  (two  spleens/ml).  When  spleen cell  preparations were treated with  anti-Thy-l.2 
serum, dead cells were removed by the techmque ofVon Boehmer and Shortman (36)  Control cells 
were treated identically to the anti-Thy-1 2-treated cells, except that normal AKR mouse serum 
was used 
Depletwn of Macrophages.  Macrophages were removed from cell preparatmns by Sephadex 
G-10 column incubation according to the method of Ly and Mishell (41) with the following modlfi- 
catmns. HEPES MEM 20%  FCS was used instead of Hanks' balanced salt solution, and a  1-h 
incubation was performed at 37°C 
M~tomyc~n C Treatment  of Cells.  Thymocytes and macrophages at 5  ×  108 cells per ml were 
treated with 50/~g/ml mitomycin C (Laboratory and Educatmnal Supplies, Los Angeles, Calif ) for 
45 min at 37°C The cells were washed twice with a 5-rain 37°C incubation between washes. This 
dose diminished the DNA synthetic response of cells to mitogenic stimulatmn to less than 10% of 
control values, yet allowed preservation of cell viability m  culture 
Ident~fwatmn of Cells  Mononuclear phagocytes (macrophages) were identified by the inges- 
tion of latex beads (1.1 ~m, Dow Chemical, Midland, Mmh ) during a 30-mm incubatmn at 37°C m 
the presence of 20% FCS (42). Latex mgestmn was performed on all cell preparations before being 
dispensed for other cell marker procedures  Surface lmmunoglobuhn-bearing cells were deter- 
mined  with  a  fluorescein-conjugated, thymocyte-absorbed rabbit  anti-mouse  lmmunoglobulin 
reagent (a gift from C. B. l~eimer, Center for Disease Control). Cells (1 ×  l0  s) m a 0.2-ml vol were 
incubated w:th a  1.100 final dilutmn of antlsera in 0.01 M phosphate-buffered saline (PBS), 0.1% 
Na azide, and 5% FCS for 30 minutes at 4°C. Cells were washed twice at 4°C over FCS, and positive 
cells were enumerated with an mcldent-illuminatmn Leltz fluorescent microscope  T cells were 
determined by microcytotoxicity (43) or indirect immunofluorescence with anti-Thy-l.2 serum 
The latter procedure was performed essentially as descmbed by Schwartz et al (44) Cells were first 
incubated with either undiluted anti-Thy-l.2 serum or normal AKR mouse serum (NMS).  The 
cells were washed and incubated with fluorescem-conjugated, rabbit anti-mouse immunoglobulln 
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fluorescent cells  in the  anti-Thy-l.2  serum  and the  NMS-incubated preparation.  Complement 
receptor-bearing lymphocytes  (CRL)  were  enumerated  with  sheep erythrocytes coated  with  a 
subagglutinating dose  of rabbit 19s anti-SRBC  (Cordls Laboratories,  Miami,  Fla.)  and  mouse 
complement (a 1:5 dilution of AKR mouse serum previously absorbed at 4°C against SRBC) (45) 
Antibody-coated SRBC without complement served as control. Only cells surrounded by three or 
more SRBC (macrophages excluded) were considered CRL. Lymphocytes bearing receptors for the 
Fc portion of immunoglobulin were enumerated indirectly according to the method described by 
Dickler and Kunkel (46) in which aggregated human IgG and a fluorescein-conjugated, goat anti- 
human T-chain reagent were used (supplied by C.  B. Relmer, Center for Diseases Control). The 
latter  reagent  did  not  bind  mouse  cells  directly.  At  least  300  cells  were  examined  for  each 
determination.  When  a  particular  marker  comprised  a  small  percentage  of  the  cells  being 
examined, effort was made to examine 1,000 or more cells. 
Mitogen Sttmulatton.  All experiments were performed with several doses of mitogens: phyto- 
hemagglutinin, diluted according to manufacturer's instructions, 0.25-1.0 ~l/ml (Difco Laborato- 
ries);  concanavalin A,  0.1-1.0  ~g/ml  (Con A,  Pharmacia,  Piscataway,  N.  J.);  and Salmonella 
enterttidts  lipopolysaccharide, 1-10 ~g/ml (Difco Laboratorms). Results reported reflect optimums 
from dose-response curves. 1-ml cultures of 106 cells in serum-free, supplemented MEM containing 
5 x  10  -5 M 2-ME were incubated for 3 days. 18 h before harvest, 1 ~Ci [3H]thymidine (6 7 Ci/mM, 
New England Nuclear, Boston, Mass.) was added. Cultures were harvested manually  Cells were 
pelleted,  and the pellets  were precipitated with cold 5%  trichloroaeetic acid,  washed twice  in 
methanol,  and solubihzed at 50°C  in 0.4  m] NCS  reagent  (Amersham/Searle Corp.,  Arhngton 
Heights, Ill.); radioactivity was determined by liquid scintfllatmn counting. 
Results 
Cell Preparations and the Optimal Conditions for the In Vitro Induction of 
Helper Cell Function.  Preliminary experiments were performed to determine 
the optimal thymocyte cell number,  proportion of macrophages,  antigen  dose, 
and duration  of the helper cell induction  culture.  It was found that  1.5  ×  107 
thymocytes and 5 ×  105 macrophages cultured for 4 days with either 0.1/xg KLH 
or 0.5 gg FTG are the optimal conditions for generating helper cells. Cells from 
this culture enhance the anti-DNP PFC response of hapten-primed,  spleen cell 
cultures to hapten-carrier  conjugates. The enhancement of indirect (IgG) DNP- 
PFC responses varied in parallel with direct (IgM) DNP-PFC responses (Fig. 1). 
The presence of macrophages in the thymocyte cultures improves cell culture 
recovery and viability (25-45% viable cell recovery within the protocols outlined 
in Fig.  1), but does not obviate the addition of varying amounts of dead cells to 
the  recipient  cultures.  This  might  affect  recovery  of spleen  cells  from  the 
cultures and,  therefore, the results expressed as DNP-PFC per culture.  In the 
experiments reported here, individual spleen cell-culture recoveries were within 
20% of the mean recovery for all cultures within any given experiment. 
The  characteristics  of the  cell  preparations  before and  after  4  days  of co- 
culturing is shown in Table I.  B-cell contamination  is minimal  as assessed by 
membrane markers (SIg, Fc, CRL) and by the absence of a response to the B-cell 
mitogen lipopolysaccharide  (Table II).  No PFC  are  generated  in this  culture 
(n =9). 
Nylon wool purification of corisone-resistant thymocytes yields 50-70% recov- 
ery, removes contaminating  B cells, and results in an effluent population with 
improved viability (90-98% vs. 60-80% viability for the starting pool). 
PEC  obtained  from  mice  injected  with  proteose peptone  broth  are  60-75% 
phagocytic as judged by uptake of polystyrene beads. Purification by adherence 
substantially  increases  the  proportion  of phagocytic  cells.  Macrophages  are 680  GENERATION  OF  T-HELPER  CELLS  IN  VITRO.  I. 
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FIG.  I.  Optimal  conditions for the in vitro generation  of helper cells  Thymocyte-macro- 
phage cultures primed to KLH  and assayed for helper cell activity as described m  the text, 
except that in (A) the number  of macrophages  m  the carrier-induction  culture was varied, 
(B) the duration of  culture before transfer to the assay culture was varied, and (C) the dose 
of carrier  (KLH)  was  varmd.  Direct  (O-O)  and  indirect  (O-©)  DNP-PFC  _+ SD  of 
triplicate cultures;  horizontal  lines  represent  background  dlrect  and  indirect DNP-PFC 
responses of spleen cell  cultures not receiving helper cells 
TABLE  I 
Composition of Thymocyte-Macrophage Cultures 
Thymocyte-macro-  Normal  spleen 
Marker*  Thymocytes$  Macrophages§  phage  cultureq I 
Latex +  0  04  ±  0  07  (n  =  14)¶  96  9  ±  1  2  (n  =  36)  2  2  _+  0  4  (n  =  16)  3  9  ±  1  8  (n  =  17) 
O +  (fluorescence)  96 8  -+ 4  7  (n  =  9)  1 4  _+  0  3  (n  =  7)  90 4  ±  4  2  (n  =  8)  40 5  ±  5  3  (n  =  17) 
O +  (cytotoxlclty)  99 9  -+  0  (n  =  14)  ND  96 6  ±  1  6  (n  =  5)  44 8  ±  2  2  (n  =  10) 
Slg +  0  07  ±  0  08  (n  =  13)  0  5  -+  0  2  (n  =  9)  0  09  ±  0  02  (n  =  12)  48 0  _+  5  4  (n  =  17) 
CRL +  0  07  _+  0  03  (n  =  11)  0  3  -+  0  1  (n  =  9)  0  01  -*  0  01  (n  =  10)  37 3  ±  7  0  (n  =  14) 
Fc +  0  02  ±  0  09  (n  =  9)  0  3  ±  0  3  (n  =  7)  0  04  _+  0  10 (n  =  10)  51 6  ±  8  3  (n  =  14) 
* Markers latex  +, percent  cells  phagocytosmg latex  beads,  O  +, percent  cells  wlth  O (thy-1  2) isoantlgen,  percent  cells  (bearing 
surface  membrane Immunoglobuhn, CRL  +,  percent  cells  wlth  receptors  for  complement (macrophages excluded),  Fc*,  percent 
cells  wlth  receptors  for  the  Fc  porhon  of  immunoglobuhn (macrophages excluded) 
Cortisone  remstant,  nylon  wool  purified  thymocytes 
§  Adherent  peritoneal  exudate  cells 
II Thymocyte-macrophage cultures  (1  5 x 10  7  thymocytes  and  5 x 10  s  macrophages) Markers  done  after  4  days  of  co-culturing 
¶  Percent  pomtlve  cells  _+  SD, n = number of  determinations 
recovered for  culture by scraping with a rubber policeman, which, in our hands, 
results  in as much as a 50% loss  of  viability.  Unless removed by rapid filtration 
at 4°C over cotton wool in low ionic strength  buffer (36), dead macrophages 
markedly depress thymocyte cell-culture  recovery and the induction of helper 
cell  function. 
If  glass  beads that contain adherent macrophages are introduced directly  into 
the thymocyte culture, the cell  loss  sustained by scraping and removing dead 
cells is eliminated.  The disadvantage  of this procedure is that the adherent 
population cannot be adequately characterized. Viability can be evaluated by 
tube incubation with trypan blue and examination of  the beads under low-power 
microscopy.  The number  of cells added to the glass-bead  column  minus the 
number of nonadherent cells  recovered served as an estimate of  the number of 
macrophages bound to a given volume of beads. This method of enumeration, 
although it may represent  a slight overestimation,  gives a macrophage  dose- 
response curve similar to  that obtained with plastic  dish-adherent macrophages 
(Fig. I A). Moreover, when membrane  marker studies are done on the eluted, 
nonadherent cell  fraction,  there is  virtually  complete recovery of  the nonphago- 
cytic component of  the PEC population (n=4). J.  STEVEN  McDOUGAL  AND  DAVID  8.  GORDON 
TABLE  II 
Response of Thymocyte-Macrophage Cultures to Mitogens* 
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Thymocyte-macro-  Normal spleen  Mltogen$  Thymocytes§  Macrophage~]  phage culture¶ 
Medm  0 8  _+ 0 2  0.5  -  0  1  1.5  +_ 0.2  0.8  +  0.1 
PHA  37.3  -+ 3  1  0.6-+  01  91.1  -+ 63  758_  54 
Con A  10 6  _+  1.3  0.7  _+  0.2  149 6  _+  11.0  100.4  _+  7.1 
LPS  09_+  0.2  05-+  01  2.0_+  0.3  510_+  1.2 
* Incorporation of trltlated  thymldme expressed as cpm ×  10  -3 +_  SD of tmplicate cultures 
$ Values given for mitogens are optimums from dose-response curves (see text): PHA 0 5  ~l/ml, 
Con A  1.0 ~g/ml, LPS  I0 ~g/ml. 
§ Cortisone resistant, nylon wool purified thymocytes (10  s cells/culture). 
[[  Adherent peritoneal exudate cells (10  s cells/culture) 
¶ Thymocyte culture contaimng 3% macrophages (10  s cells/culture) 
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FIG.  2.  Dose  response  of  in  vitro  generated  helper  cells.  Varying  numbers  of  cells 
(ATCkLH) from thymocyte-macrophage cultures premed to KLH were transferred to hapten- 
primed spleen cell cultures with either 1 ~g DNP-KLH (Q -  0), 5 ~g DNP-FTG (A -  A), or 
no hapten-carrler  conjugate (D-  D.  After 4  days the direct DNP-PFC  _+  SD of triplicate 
cultures was determined. 
The major nonphagocytic component of the  PEC  population is T  cells.  Pre- 
treatment of the adherent cell population with anti-Thy-l.2 serum and comple- 
ment increases the percentage  of macrophages  in the population.  It does not 
affect the generation of helper cell function, making it unlikely that the perito- 
neal  exudate  T  cell  contributes  significantly  to the  generation  of helper  cell 
function in this system. 
Cellular Requirements for the In Vitro Induction of Helper Cells.  Early in 
these studies, it became apparent that, under certain conditions, the thymocyte- 
macrophage culture system nonspecifically enhanced anti-DNP-PFC responses. 
This is illustrated in Fig. 2. The thymocyte-macrophage culture cells stimulated 
splenic anti-DNP-PFC responses when added to cultures without antigen or to 
those  with  hapten  coupled to  a  noncross-reacting  carrier  (DNP-FTG) ,  i.e.,  a 
carrier other than the one used to prime the helper cell culture. This is evident 
particularly when greater numbers of helper cells are transferred.  An identical 682  GENERATION  OF  T-HELPER  CELLS  IN  VITRO.  I. 
TABLE  III 
Cellular and Antigen Requirements  for the In Vitro Generation of Helper Cells* 
Components of the first culture  Second (recipient)  spleen cell  culture 
Thymocytes$  Macrophages§  Carrie~l  Antigen 
added¶ 
Anti-DNP (DNP-PFC/cul- 
ture)  response 
Direct DNP-  Indirect 
PFC  DNP-PFC 
a  +  +  KLH  DNP-KLH  689  -+ 29**  833  _+ 99 
b  +  +  KLH  -  163 _+ 16  146 +  11 
c  +  +  KLH  KLH  183  _+ 21  156  _+ 17 
d  +  +  -  DNP-KLH  291  +_ 44  305  _+ 48 
e  +  +  -  -  167  _+ 41  203  _+ 29 
f  +  -  KLH  DNP-KLH  94  +_ 6  33  _+ 11 
g  +  -  KLH  -  80 -+ 22  40 _+ 25 
h  +  -  -  DNP-KLH  69 +  6  58 _+ 38 
1  +  -  -  -  69 _+ 6  18 _+ 19 
J  -  +  KLH  DNP-KLH  107  _+ 22  102 +_ 79 
k  -  +  KLH  -  90_+  11  68_+ 6 
1  -  +  -  DNP-KLH  79 -+ 6  58  _+ 13 
m  -  +  -  -  84  _+ 60  54  _  28 
n  DNP-KLH  69 _+ 13  40 _+ 37 
o  -  51  _+ 10  28 _+  16 
p  KLH  58 _+ 17  22  _+  11 
q  DNP-Ficoll  970 +_ 49  1,065  _+ 29 
* Cultures containing the various cellular and antigen components were cultured for 4 days  1 × 
106 viable cells from thymocyte-containing cultures or 3 × 104 cells from culture containing only 
macrophages  (reflecting their  compomtlon  in  thymocyte-macrophage  cultures)  were  trans- 
ferred to culture containing 1.5 × 107 hapten-primed spleen cells with or without hapten carrmr 
conjugates. After 4 days the specific anti-DNP PFC response was measured 
* 1.5  ×  107 nylon wool purified cortisone resistant thymocytes per culture 
§ 5  ×  105 adherent peritoneal exudate cells per culture. 
II  KLH 0 1 big/culture. 
¶ Anhgens added to second culture: DNP-KLH,  1 /~g; KLH,  1 /~g; DNP-Ficoll,  50 ng 
** Anti-DNP-PFC  _+ standard deviation of triplicate cultures. 
phenomenon  is  observed  when  the  thymocyte  macrophage  culture  is  primed 
with  a  different  carrier  (FTG). 
This  finding  prompted  us to more  carefully  examine  the  cellular  and  antigen 
requirements  for optimal  generation  of specific helper  cell  activity  (Table  III). 
Thymocytes  cultured  without  macrophages  are  ineffective  as helper  cells in this 
system.  Macrophages  cultured  alone  with  or without  carrier  and  transferred  in 
numbers  comparable  to  that  found  in  the  thymocyte-macrophage  culture  are 
only marginally  enhancing.  Cells from  thymocyte-macrophage  cultures  primed 
with  carrier  display  optimal  stimulation  of  splenic  anti-DNP-PFC  responses 
only  when  transferred  with  hapten  conjugated  to  the  same  carrier.  Transfer 
with  carrier  (not  conjugated  to  hapten)  or  without  antigen  is  not  as  effective. 
Conversely,  thymocyte-macrophage  cultures  generated  in the  absence  of carrier 
do not  stimulate  an  optimal  anti-hapten  response.  It is readily  apparent,  how- 
ever,  that  in  this  system,  the  dependence  on  the  appropriate  carrier  hapten- 
carrier  combination  for optimal  stimulation  is a  relative  phenomenon.  A  signifi- J.  STEVEN  McDOUGAL  AND  DAVID  S.  GORDON 
TABLE  IV 
Carrier Specificity of In Vitro Generated Helper Cells 
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Cells transferred 
from first cul- 
ture* 
Second (recipient) spleen cell culture* 
Antigen§ 
DNP-PFC/culture 
Direct DNP-  Indirect 
PFC  DNP-PFC 
10  x  l0  s ATCKLH  --  241  -+ 43  48 ±  12 
10  ×  105 ATCKL,  DNP-KLH  858  -+ 16  632  ±  70 
10  ×  105 ATC~LH  DNP-FyG  319  ± 55  95 ±  16 
10 ×  105 ATC~  -  240  ± 64  59 ± 6 
I0 x  105 ATCF7  G  DNP-KLH  350  ±  125  123 ±  18 
10 x  105 ATCF~¢  DNP-FyG  882  ± 6  879 ± 43 
10 x  105 ATC~o.t~ol  -  292 ± 43  79 ±  16 
10 ×  105 ATCcontml  DNP-KLH  377 -+ 21  151  ± 21 
10 ×  105 ATCcumrol  DNP-FTG  436  ± 90  157  ± 31 
-  -  52  ±  10  10 ±  13 
-  DNP-KLH  22  _+ 22  19 ±  12 
-  DNP-FTG  37 ±  13  19 ±  13 
-  DNP-Ficoll  1,040 ± 80  992  ±  136 
* Thymocyte-macrophage cultures were cultured for 4 days in the presence of 
0.1  pg/ml  KLH  (ATC~LH), 0.5  ~g/ml  FyG  (ATCF~),  or  without  carrier 
(ATCcontro,) for 4 days. 
* 1.5 × 107 spleen cells from hapten-primed mice. After 4 days the specific antl- 
DNP-PFC ±  SD response was measured. 
§ Antigens added to second culture: DNP-KLH, 1 ~g; DNP-FyG, 5 ~tg; DNP- 
Flcoll, 50 ng. 
cant stimulation  of anti-hapten  responses is provided by cells from thymocyte- 
macrophage  cultures regardless of the antigen  supplied. 
Carrier Specificity of Helper Cells  Generated In Vitro.  With knowledge  of 
the nonspecific enhancement  by thymocyte-macrophage  cultures,  we were able 
to design experiments  to determine  whether  these cultures develop significant 
carrier specificity. Thymocyte-macrophage  cultures were generated  in the pres- 
ence of KLH, FyG, or without antigen. Cultures were then tested for helper cell 
function  by  transfer  to  hapten-primed,  spleen  cell  cultures  with  either  the 
homologous  DNP-carrier  conjugate,  DNP  conjugated  to  a  noncross-reacting 
carrier,  or  without  antigen.  The  results  are  shown  in  Table  IV.  Under  these 
conditions,  despite  considerable nonspecific enhancement  of background  anti- 
DNP-PFC  responses,  optimal  enhancement  is seen  only in  a  homologous-car- 
rier, hapten-carrier  combination. In this sense the culture can be considered to 
develop carrier-specific helper cells (designated ATCKLH or ATCF~G in the tables). 
Nature  of the  Active  Cell.  Table  V  indicates  that  the  cell  generated  in 
thymocyte-macrophage  culture which is active in enhancing  carrier-specific and 
nonspecific anti-DNP-PFC  responses is a  T  cell. Treatment  of the culture with 
anti-Thy-l.2  serum  and complement  before transfer abolishes both the carrier- 
specific and nonspecific stimulation.  That the abolition of enhancement  by anti- 
Thy-l.2 serum treatment  was not caused by trivial effects such as the addition of 
dead  cells to  the  second  culture  or the  generation  of immune  complexes  was 
confirmed  by  mixing  cells treated  with  anti-Thy-l.2  serum  with  cells treated 684  GENERATION  OF  T-HELPER  CELLS  IN  VITRO.  I. 
TABLE  V 
Anti-Thy-1.2 Treatment or Macrophage Depletion of In Vitro Generated Helper Cells 
First culture* 
Cells transferred (treatment before transfer) 
Second (reclplent)  spleen cell  culture$ 
AntI-DNP.PFC  response 
(dlrect  DNP-PFC  ± SD per culture) 
Antlgen added to second culture 
None  DNP-KLH  DNP.FTG 
5  ×  10s ATCKIH  (anh-Thy-1 2  +  C')  86  ±  36  93  ±  27  86  ±  43 
I0 x i05 ATCKI.  (anh.Thy-I 2 + C)  82 ± 21  106 ±  33  96 ± 30 
5 x  10  b  ATCkIH (NMS  +  C')  124 ± 41  693 ±  139  192 ± 70 
10 x  10s ATCM.  (NMS  + C')  155 ± 27  797 ±  42  200 ± 89 
5 x  10  s ATCktH  (antl-Thy-1  2 +  C') plus 5 ×  105  89 ± 84  704 ± 46  179 ±  100 
ATCK,.  (NMS  +  C') 
No cells transferred  79  ±  21  93  ±  41  69  ±  21 
5  ×  10  ~ ATC~Is  (mob depleted}  182  _+  51  725  -+  26  127  _+  29 
10  ×  105 ATC~H  (m~b depleted)  165  ±  17  886  ±  119  273  ±  27 
5  ×  10  s ATCK~.  (no treatment)  192  ±  21  811  ±  70  237  ±  37 
10  ×  10  ~ ATC~L.  (no treatment)  189  ±  53  824  ±  55  268  ±  17 
5  ×  105ATC~IH (m~b depleted) plus 5  x  10~ ATChe~  141  ±  31  790  ±  57  258  ±  41 
(no treatment} 
No cells transferred  69  ±  12  14  ±  16  38  ±  16 
* Thymocyte macrophage culture cells  primed wlth KLH  (ATCK~x) were treated wlth antl-thy-I 2 sere or NMS  and complement 
before transfer  to spleen cell  cultures In the second set  of  experiments  ATCK~. were depleted of  macrophages by Sephadex G-10 
column mcubatlon before transfer 
1 5 × 107 spleen cells  cultured wlth cells  from the first  culture was treated, as mehcated and either 1 ~g DNP-KLH,  5 ~g DNP- 
FTG, or no antlgen was added  After 4 days the dlrect  antl-DNP PFC  response  ±  SD of triplicate  cultures was assayed 
with NMS.  When  macrophages  are removed from the thymocyte-macrophage 
culture before transfer, no significant effect is seen (Table V). The active cell is 
therefore a T cell. 
Requirement for In Vitro T-CeU Proliferation in the Generation of Functmnal 
T-Helper Cells.  In vivo models of T-helper cell generation require a critical 2- 
to 3-day period ofT-cell proliferation in the presence of antigen. Once generated, 
the T-helper cell is functionally resistant to X-irradiation or anti-mitotic drugs 
(9, 14, 47-49). It was therefore of interest to examine whether cellular prolifera- 
tion was required in the thymocyte-macrophage  culture  system before  helper 
cell activity was manifest. 
Thymocyte-macrophage cultures were treated with mitomycin C, either at the 
initiation  of culture  or after  4  days, just before  transfer,  and  then  tested  for 
helper  cell  activity.  Efficacy  of mitomycin  C  treatment  was  assessed  by  the 
reduction  in  PHA  and  Con A  responses  to  less  than  10%  of control  values. 
Control cultures with mitomycin C-treated cells  and either untreated ATC or 
DNP-Ficoll  (which stimulates B  cells directly)  were used to monitor the poten- 
tial responsiveness of the recipient spleen cell cultures,  i.e.,  to insure that any 
inhibition found was not due to mitomycin C leaching from the cells. The results 
are  shown  in  Table  VI.  Mitomycin  C  treatment  of  thymocyte-macrophage 
preparations  at  the  onset  of culture  abolished  the  generation  of helper  cell 
function.  If the culture is treated after 4 days, just before transfer,  helper cell 
activity  can  be  demonstrated.  This  is  true  for  both  the  carrier-specific  and 
nonspecific enhancing effects. 
In  separate  experiments,  thymocytes  and  macrophages  were  treated  sepa- 
rately with mitomycin C, combined with untreated macrophages or thymocytes, 
respectively, and cultured for 4 days with carrier protein. The abolition of helper J.  STEVEN  McDOUGAL  AND  DAVID  S.  GORDON 
TABLE  VI 
Mitomycin C Treatment of Macrophage-Thymocyte Cultures 
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First culture* 
Cells transferred 
Second (recipient) spleen cell culture~ 
Antl-DNp response (direct DNP-PFC per culture -+ SD) 
Cultured in the presence of 
DNP-KLH plus 5 
DNP-KLH  DNP-FTG  DNP-FIcoll  x  1@ ATCkLH 
5  x  10  ~ ATCKL. mltemycm  93 ±  27  79 ±  52  93 ±  47  2,143  ±  53  1,126 ±  51 
treated day 0 
5  x  10  s  ATChL.  mttomycln  183 ±  43  855 ±  64  367 ±  67  2,178 -+ 247  1,229 ±  98 
treated day 4 
5 x  105 ATCKIs untreated  179 -+ 97  1,075 ±  88  340 ±  63  2,782 ±  482  1,343 ±  99 
-  103 ±  10  41 ±  45  82 ±  74  2.616  ±  152  1,075  ±  88 
* Thymocyte-macrophage cultures primed with KLH (ATChLH) were treated with mltomycln C at the mlttatlon (day 0) or after 4 
days of culture just before transfer to spleen cell cultures 
1 5  x  107 spleen  cells  per culture were co-cultured with cells transferred from  the first culture  as mdmated  and  either no 
additional antigen, 1/~g DNP-KLH, 5 pg DNP-FTG, 50 ng DNP-Fmon, or 5 × 106 untreated ATCKL  H  with 1 p.g DNP-KLH  After 4 
days, the dtrect DNP-PFC _+ SD oftrlphcate cultures was measured 
cell activity was seen only in cultures containing mitomycin C-treated thymo- 
cytes.  Treatment  of macrophages  alone  did  not  diminish  the  generation  of 
helper cell function. Thymocyte proliferation in vitro before the manifestation of 
helper cell function is a  critical  inductive event in this system.  These results 
correlate  with  in  vivo  requirements  for  the  generation  of helper  cells  from 
unprimed cells (9,  14). 
Cooperative  Interactions Between the In Vitro Generated T-Helper Cell and 
Hapten-Pnmed Spleen  Cells.  In vitro  generated  helper cell function is ulti- 
mately  expressed  as  a  stimulation  of B-cell maturation  and  proliferation  to 
DNP-specific PFC within the spleen cell cultures. This stimulation could require 
additional  splenic  T-cell  cooperation  (a  T-T-B-cell  interaction),  be  mediated 
through cooperative effects of splenic macrophages (a T-m~b-B-cell  interaction), 
or act directly on B cells (a T-B-cell interaction).  To test this, recipient spleen 
cell cultures were treated with anti-Thy-l.2 serum and complement or depleted 
of macrophages.  Effectiveness of depletion was assessed by membrane marker 
studies and,  functionally,  by the primary  in vitro response to sheep erythro- 
cytes, a response known to require T cells (50) and macrophages (51). Preserva- 
tion of B-cell precursors in these populations was assessed, functionally, by the 
DNP-PFC response to the T-independent  antigen,  DNP-Ficoll (52). 
Results of T-cell depletion experiments are shown in Table VII. Splenic T cells 
are not absolutely required for the carrier-specific or nonspecific enhancement of 
the DNP-PFC response by T-helper cells generated in vitro. 
Macrophage  depletion  of the  responding  spleen  cell  culture,  sufficient  to 
abrogate the primary in vitro response to SRBC, markedly blunts the carrier- 
specific enhancement,  but has little or no effect on nonspecific enhancement.  It 
is noteworthy that  macrophages had to be removed from both the spleen cell 
population and the transferred thymocyte-macrophage culture in order for these 
differences to be observed (Table VIII). Apparently, the small number of macro- 
phages  transferred  with  the  cultured  thymocytes is  sufficient  to restore  the 
carrier-specific stimulation of macrophage-depleted spleen cultures. 686  GENERATION  OF  T-HELPER  CELLS  IN  VITRO.  I. 
TABLE  VII 
Effect of In Vitro Generated Helper Cells on T-Depleted Spleen 
First  culture* 
Cells  transferred 
Second (recipient)  spleen cell  cultures 
Anh-DNP  response (direct  DNP-PFC  _+ SD per culture) 
Antigen§  Antl-Thy 1 2  +  C'  NMS  +  C' 
treated spleen  treated spleen 
5  x  10  s 
5  x  10  s 
5  x  105 
5  ×  l0  s 
5  ×  l0  s 
5  x  105 
5  x  105 
5  x  l0  s 
5  x  l0  s 
ATCKLH  -  124  -+  1(~1  82  -+  10 
ATCKLn  DNP-KLH  1,030  -+ 93  769  +- 49 
ATCKL.  DNP-FyG  168  -+  16  127  ±  21 
ATCvvc  -  113  -+  20  106  +_  16 
ATCF~G  DNP-KLH  179  -+  39  151  _+  6 
ATCFTG  DNP-FTG  780  +-  113  673  -+  70 
ATC¢o.tro~  -  93  _+  41  76  _+  16 
ATC~o.t~.  DNP-KLH  192  -+  31  158  +-  12 
ATC~o.,~,,  DNP-FyG  144  -+  37  141  _+  6 
-  -  52  -+  I0  38  _+  21 
-  DNP-KLH  58  _+  22  45  _+  6 
-  DNP-F~/G  58  _+  42  35  +  12 
-  DNP-FIco]I  1,508  _+  41  958  _+  68 
-  SRBC  107  _+  44¶  2,487  _+  44 
* Thymocyte-macrophage  culture  cells  primed  with  KLH (ATC~LH), F,/G (ATCvTc),  or 
without carrier  (ATCcont~ol) 
S Spleen  cells  treated  with either  anti-Thy 1 2 sera  and complement or  control  AKR 
NMS and  complement,  dead  cells  removed, and  cultured  at  i × 107  cells  per  culture. 
§  Antigens DNP-KLH, 1.0/xg;  DNP-FTG, 5/xg;  DNP-FmoII, 50  ng, or  3 × 10  ~  SRBC. 
I[  Direct  (IgM) DNP-specific PFC per culture -+ SD of  triphcate  cultures 
¶ Primary in vitro  response to unconjugated SRBC. 
Discussion 
The present work was designed to establish the conditions for a reliable  in 
vitro system of  generating T-helper cells  by using well-defined populations of 
cells. Cortisone-resistant thymocytes were selected because they represent a 
more mature population of  thymus cells  enriched for  helper cell  precursors (53). 
Nylon wool filtration  of  thymocytes and combination of  these cells  with adher- 
ent, peritoneal exudate macrophages effectively  establish a viable thymocyte 
culture which can be primed with carrier  protein to develop significant  carrier- 
specific  T-helper cell  function (Tables III-V). 
B-cell contamination in this  culture system is negligible (Tables I and II). 
Minor nonphagocytic or nonthymocytic  cellular components  in this culture 
system are  peritoneal exudate T cells.  These cells  are  reportedly a good source of 
antigen-reactive T cells  (44).  Several lines  of  evidence mitigate against a major 
role  for this  cell  in the system described. Anti-Thy-l.2 serum and complement 
treatment of  the adherent cell  population before combination with thymocytes 
does not affect  the generation of  helper cells.  Pretreatment of  the adherent cell 
population with mitomycin C  does not affect  the generation of helper cells, 
whereas pretreatment of the thymocytes or the combined culture (Table VI) 
abolished helper cell  generation. 
With the cell  populations described in this  communication, our results  con- 
firm the basic observations of  Erb and Feldmann (29-31)  that macrophages are J.  STEVEN  McDOUGAL  AND  DAVID  S.  GORDON 
TABLE  VIII 
Effect of In Vitro Generated Helper Cells on Maerophage-Depleted  Spleen 
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First culture* 
Cells transferred 
Second (recipient) spleen cell cultures 
Anti-DNP response (direct DNP-PFC per culture ± SD) 
m~b depleted  Normal spleen 
Antigen  spleen cells  cells 
5 × 105 m~b depleted ATCKL  H  --  127 ± 26  122 -+ 51 
5 x  105 m~b depleted ATCKLH  DNP-KLH  330 ± 45  725 ± 26 
5 × 105 m~ depleted ATC~L  H  DNP-F~,G  161 _+ 57  187 +_ 29 
10 ×  105 m~b depleted ATC~LN  -  124 ± 64  165 ±  17 
10 × 105 m~b depleted ATCKL  H  DNP-KLH  337 ± 26  886 ±  119 
10 × 10  s m~b depleted  ATChLH  DNP-FTG  103 ± 63  273 ± 27 
5 × 105 ATCKIH  --  151 ± 31  158 ± 39 
5 × 105 ATC~LH  DNP-KLH  797 ± 84  811 -+ 70 
5 × 10  s ATCKL.  DNP-FTG  254 ± 39  237 ± 37 
10 x  105 ATCk~..  -  244 ±  16  189 ± 53 
10 x  10  ~ ATChLH  DNP-KLH  491 ± 65  824 -+ 55 
10 x  105 ATCKL.  DNP-FTG  258 ± 66  258 ±  18 
-  -  69  ±  12  58 -+ 6 
-  DNP-KLH  14 ±  16  76 ± 6 
-  DNP-FTG  38 ±  16  82 -+ 41 
-  DNP-Ficoll  1,067 ±  109  1,380 ± 80 
-  SRBC§  148 ± 30  2,336 ±  127 
* Thymocyte-macrophage culture cells primed to  KLH are transferred directly to  spleen cell 
cultures or macrophage depleted by Sephadex  G-10 column incubation before transfer. 
S Spleen cell cultures either macrophage depleted by Sephadex G-10 column incubation or cul- 
tured without depletion at 1.0 × 107 cells per culture in the presence of either 1/~g DNP-KLH, 5 
~tg DNP-F~G, 50 ng DNP-Ficoll, or 3 x 10  e SRBC. After 4 days the direct DNP-PFC response ± 
SD of trlphcate cultures was measured. 
§ Primary m vitro PFC response to SRBC. 
essential for inducing an active T-helper cell in vitro  (Tables III and V).  We 
extend these  results to  show that  thymocyte proliferation is required for  the 
induction of functional T-helper cells (Table VI), and that these cells display an 
antigen-specific as well as nonspecific capacity to stimulate B-cell responses to 
antigen (Tables III and IV). 
The  macrophage  has  been  shown to  be  essential  to  a  variety of T-cell re- 
sponses, including antigen presentation (19-21), T-cell proliferation in the pres- 
ence of antigen (22-23),  mitogen responsiveness (24,  Table II),  and the  mixed 
lymphocyte reaction (25). Macrophages improve thymocyte cell culture recovery 
and viability (26). 
The antigen requirements (Table III) and specificity (Table IV) of this culture 
system suggest a  more critical role for the macrophage than merely facilitating 
thymocyte integrity in vitro.  The  experiments with  mitomycin C  (Table VI) 
indicate that T-cell proliferation is required in this system before the expression 
of helper cell function. Based on our data,  the predominant role of the macro- 
phage in this system is in facilitating the proliferative expansion of thymocytes 
into functional carrier-reactive helper cells. While it is probable from available 
data (19, 21, 22, 30) that antigen acts in the induction of specific T-cell prolifera- 688  GENERATION  OF  T-HELPER  CELLS  IN  VITRO.  I. 
tion, we have not presented formal evidence that this is the mechanism in our 
system.  It is possible that the thymocyte proliferation  in this system is undi- 
rected and that antigen-bound macrophages serve to selectively enrich prolifer- 
ating cells which are antigen specific. The requirement for T-cell proliferation 
distinguishes  this  mechanism of generating helper cells from another in vitro 
system described by Ben-Sasson et al.  (27), where antigen-pulsed macrophages 
have been used to enrich antigen-specific T cells from mice presensitized in vivo. 
Their system enriches by selection rather than proliferation. 
Analysis of the antigen requirements reveals that carrier-specific and nonspe- 
cific T-helper cell function is generated in vitro. Optimal stimulation of splenic 
DNP-PFC  responses to  a  hapten-carrier  conjugate  is provided by thymocyte- 
macrophage cultures primed to the carrier.  Stimulation is substantially less if 
the helper cell culture is not primed with carrier or is primed with a noncross- 
reacting carrier  (Tables III and IV). In the sense that optimal enhancement is 
seen only in the appropriate combination of carrier in the helper cell culture and 
carrier-hapten  conjugate in the  assay culture,  this  system generates  specific, 
carrier-reactive T-helper cells. 
Enhancement  of the  anti-DNP-PFC  response is also seen under  conditions 
that cannot be considered antigen specific. Both carrier-primed  and unprimed 
cells from helper cell cultures stimulate a small but reproducible enhancement 
of background  splenic  DNP-PFC  responses  in  the  absence  of hapten-carrier 
conjugate (Tables III and IV). This nonspecific effect is particularly striking if 
greater numbers of activated T cells are used (Fig. 2). The nonspecific response 
is further enhanced in the second culture in the presence of hapten coupled to a 
noncross-reacting  carrier  (Fig.  2,  Table IV). The marginal  but consistent aug- 
mentation of the nonspecific response in the presence of an irrelevant hapten- 
carrier  conjugate requires  that  macrophages  be present  in  the  assay culture 
(Table VIII), and its mechanism is further clarified in the companion paper. 
Nonantigen-specific enhancing effects of activated T cells have been described 
in  other  systems.  The  activation  of T  cells  to  histocompatibility  differences 
results in a cell active in enhancing B-cell responses to T-dependent antigens (1, 
53-55).  When looked for, nonspecific enhancing  effects have even been demon- 
strated with in vivo generated,  carrier-specific T-helper cells (18,  56).  In their 
system, Erb and Feldmann  do not describe an enhancing  effect of cultured T 
cells that is independent of antigen  (29-31). There are several possible reasons 
for this discrepancy. They used unprimed spleen cells as recipients of activated T 
cells,  whereas  we used hapten-primed  spleen cells.  In our system, the  major 
differences between primed  and  unprimed  spleen  cells  in  culture  are  in  the 
magnitude of the IgM-PFC response and the fact that IgG-PFC are not detected 
unless hapten-primed  cells are used.  It is noteworthy in this  regard  that  the 
allogeneic effect, a  T-cell derived nonspecific stimulation of B-cell responses to 
antigen,  is generally not demonstrable in unprimed cells (1, 57). The low levels 
of background  DNP-PFC in unprimed  cells,  the inherent  variability between 
cultures,  polyclonal B-cell activation from other sources in vitro such as FCS 
(55),  and the method of enumerating  DNP-specific PFC  (hapten inhibition vs. 
subtraction technique), make precise demonstration of a nonspecific stimulatory 
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Macrophage depletion of recipient spleen cell cultures revealed a difference in 
the mechanism of the specific and nonspecific stimulation of B-cell responses by 
cultured  T-helper  cells.  It  is  difficult  to  totally  deplete  a  cell  population  of 
macrophages.  In our hands,  the  most effective method without proportionate 
changes  in  T  and  B  cells  is  Sephadex  G-10 column  incubation.  Macrophage 
depletion of both the spleen cell cultures and the transferred thymocyte culture 
markedly blunts the carrier-specific effect of in vitro generated T-helper cells 
(Table VIII), findings consistent with those observed with in vivo generated T- 
helper cells (16).  Although macrophages are not the active cell (Tables III and 
IV), the small number transferred  with the primed thymocyte-culture cells is 
apparently  sufficient  to  restore  the  T-m~b-B-cell  interaction  in  macrophage- 
depleted spleen cell cultures. The nonspecific enhancement of background DNP- 
PFC due to cultured thymocytes does not require additional macrophage inter- 
action and appears to act directly on B cells. 
Summary 
A  sequential  mouse cell culture  system is  described for the  induction  and 
assay of T-helper cells. Unprimed, cortisone-resistant,  nylon wool-purified thy- 
mocytes cultured with adherent peritoneal exudate cells can be primed in vitro 
with  soluble  carrier  protein  to  generate  carrier-reactive  helper  cells.  These 
cultured  cells  enhance  the  anti-hapten  plaque-forming  response  of hapten- 
primed spleen cell cultures to hapten carrier conjugates. The culture conditions, 
cellular manipulations,  and antigen requirements for the optimal induction of 
helper cells with these purified cell populations is presented. The active helper 
cell generated  in this  culture system is a  thymus-derived cell which requires 
macrophages  for  its  induction  and  must  be  proliferate  in  vitro  before  the 
manifestation  of helper-cell function.  Helper cells generated in vitro stimulate 
both  carrier-specific  and  nonspecific  enhancement  of splenic  anti-hapten  re- 
sponses. The carrier-specific and nonspecific enhancement can be distinguished 
by the requirement for antigen  in the helper cell and spleen cell cultures,  the 
dose of helper cells added to the spleen cell cultures, and by the requirement for 
additional splenic adherent accessory cell interactions. 
Received for publication I  November 1976. 
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